| Medical and Health Sciences | 2021-2025 | 68 | US 29 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 147 | US 82 | 99.54 |
| Nephrology | Lifetime | 91 | US 53 | 99.39 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 12 | US 9 | 99.93 |
| Nephrology | 2021-2025 | 19 | US 9 | 99.55 |
| Surgery | 2021-2025 | 256 | US 105 | 98.35 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 450 | US 199 | 94.15 |
| Diabetes Treatment and Management | Lifetime | 91 | US 43 | 99.57 |
| Chronic Kidney Disease and Diabetes | Lifetime | 64 | US 33 | 99.49 |
| Diabetes Management and Research | Lifetime | 278 | US 140 | 98.92 |
| Pancreatic function and diabetes | Lifetime | 430 | US 195 | 98.71 |
| Diet and metabolism studies | Lifetime | 667 | US 296 | 98.84 |
| Renal and Vascular Pathologies | Lifetime | 233 | US 137 | 98.36 |
| Renal Diseases and Glomerulopathies | Lifetime | 250 | US 108 | 98.63 |
| Dialysis and Renal Disease Management | Lifetime | 258 | US 113 | 98.66 |
| Metabolism, Diabetes, and Cancer | Lifetime | 373 | US 172 | 98.55 |
| Pharmacology and Obesity Treatment | Lifetime | 153 | US 72 | 98.09 |
| Advanced Glycation End Products research | Lifetime | 467 | US 127 | 94.58 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 558 | US 166 | 91.07 |
| Potassium and Related Disorders | Lifetime | 512 | US 247 | 91.28 |
| Neurological and metabolic disorders | Lifetime | 856 | US 338 | 87.79 |
| Apelin-related biomedical research | Lifetime | 680 | US 195 | 87.09 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 4 | US 1 | 99.78 |
| Diabetes Treatment and Management | 2021-2025 | 15 | US 10 | 99.87 |
| Pancreatic function and diabetes | 2021-2025 | 12 | US 6 | 99.70 |
| Diabetes Management and Research | 2021-2025 | 15 | US 11 | 99.68 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 11 | US 8 | 99.59 |
| Diet and metabolism studies | 2021-2025 | 44 | US 11 | 99.22 |
| Hormonal Regulation and Hypertension | 2021-2025 | 17 | US 10 | 99.11 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 58 | US 20 | 98.56 |
| Pharmacology and Obesity Treatment | 2021-2025 | 22 | US 12 | 97.83 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 216 | US 83 | 96.21 |
| Dialysis and Renal Disease Management | 2021-2025 | 214 | US 41 | 95.61 |
| Potassium and Related Disorders | 2021-2025 | 81 | US 33 | 93.17 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 261 | US 113 | 81.48 |
| Organ Donation and Transplantation | 2021-2025 | 769 | US 301 | 80.23 |
| Apelin-related biomedical research | 2021-2025 | 228 | US 36 | 66.17 |
| Ion Transport and Channel Regulation | 2021-2025 | 780 | US 228 | 51.96 |
